Anson Funds Management’s RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 RXIIW Stock Holding History

Anson Funds Management’s Portfolio RXIIW Stock Details RXIIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-218,023	Closed	-$255K	–	63
2018 Q3	$255K	Hold	218,023	–	–	0.09%	14
2018 Q2	$421K	Sell	218,023 -4,150	-2%	-$1.8K	0.25%	18
2018 Q1	$715K	Sell	222,173 -1,999,549	-90%	-$1.3M	0.53%	22
2017 Q4	$1.24M	Sell	2,221,722 -500	-0%	-$82	0.83%	28
2017 Q3	$1.07M	Buy	+2,222,222	New	+$428K	0.16%	46

Anson Funds Management's RXIIW Position: Q4 2018 in Review

Anson Funds Management sold out of RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) in Q4 2018, closing a stake of 218,023 shares — an estimated $255K sold.

Anson Funds Management first reported a position in RXIIW in Q3 2017 and held it in 5 quarters. The position peaked at $1.24M in Q4 2017. 0 funds tracked by Wall St. Rank hold RXIIW as of Q4 2018.

Anson Funds Management reported no remaining RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 position as of Q4 2018 after selling out during the quarter.
Anson Funds Management sold 218,023 RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 shares in Q4 2018, an estimated $255K.
Anson Funds Management first reported a position in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 in Q3 2017 and held it in 5 quarters.
Anson Funds Management's RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 position peaked at $1.24M in Q4 2017.
0 funds tracked by Wall St. Rank held RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 as of Q4 2018.

Based on Anson Funds Management's 13F filing for Q4 2018, filed 14 Feb 2019.